2018 DIAD Family Conference Agenda
<< Back to 2018 Family Conference
Master of Ceremonies
Eric McDade, D.O., Washington University School of Medicine, St. Louis, MO
Welcome remarks and updates
Harry Johns, President and CEO, Alzheimer’s Association
2008 – 2018: Ten Years of the Dominantly Inherited Alzheimer Network (DIAN)
John C. Morris, M.D., Washington University School of Medicine, St. Louis, MO
Family presentation
Going Mobile: The Value of Remote Assessments for Alzheimer’s Disease Research
Jason Hassenstab, Ph.D., Washington University School of Medicine, St. Louis
Q & A – Guided discussion: The use of mobile technology and AD registries to advance our understanding of AD and accelerate treatment
Moderator: Eric McDade
Panelists:
- Yen Ying Lim
- Lara Mangravite
- Jason Hassenstab
- Family members
Induced Pluripotent Stem Cells (iPSC): The skin in the game
Celeste Karch, Ph.D., Washington University School of Medicine, St. Louis
Q & A – Fibroblast derived iPSCs in Alzheimer disease the how they are helping advance our understanding of Alzheimer disease and accelerate treatment advancements
Moderator: Eric McDade
Panelists:
- Steve Wagner
- Eric Karran
- Celeste Karch
- Lindsay Hohsfield
Family presentation
DIAN-TU updates
Randall Bateman, M.D., Washington University School of Medicine, St. Louis
Closing remarks/Lunch with speakers/Poster session
Primary Prevention
Eric McDade, D.O., Washington University School of Medicine, St. Louis
Concurrent practical information session topics
-
- The ethical implications of pre-symptomatic testing in Alzheimer’s
prevention trials – Josh Grill, M.D., University of California Irvine - Alzheimer’s 101: Basics of the science with Q & A – Nick Cochran, Ph.D.,
HudsonAlpha Institute for Biotechnology - Part 1: Legal/Financial specific to U.S. – Ruth Drew, M.S., L.P.C., Alzheimer’s Association
- Part 2: Legal/Financial specific to U.S. – Ruth Drew, M.S., L.P.C., Alzheimer’s Association
- Breaking the silence: How to tell family and friends about DIAD – David
Parris, L.C.S.W., Alzheimer’s Association
- The ethical implications of pre-symptomatic testing in Alzheimer’s
Support sessions
Symptomatic family members: symptomatic individuals only
Asymptomatic, at-risk family members (2 groups)
Supporting family/friends of symptomatic individuals
Supporting family/friends of asymptomatic individuals
Grupo para hispanohablantes